Former GSK CEO named Optum head

Mar 13, 2018

UnitedHealth Group has named its board member and former GlaxoSmithKline head Andrew Witty as chief executive of its pharmacy benefit unit, Optum, which manages drug benefits and offers healthcare data analytics services.

According to Optum, the unit's current CEO, Larry Renfro, will instead lead investment initiatives through Optum Ventures.

Witty's appointment will be effective July 1 with the former GSK head stepping down from the UnitedHealth Group board effective immediately.

Read the Reuters report

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments